When is positron emission tomography really necessary in epilepsy diagnosis?

Current Opinion in Neurology

Volumn 15, Issue 2, 2002, Pages 191-195

  Theodore, William H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EPILEPSY; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; REVIEW;

DISEASE PROGRESSION; EPILEPSY; HUMANS; MAGNETIC RESONANCE IMAGING; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036219728     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200204000-00011     Document Type: Review

References (52)

1. Presurgical evaluation of epilepsy
2. Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography
3. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy: A prospective study in 100 patients
4. 18F-labeled 2-deoxy-2-fluoro-D-glucose positron-emission tomography scans for the localization of the epileptogenic foci
5. Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy
6. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy
7. Comparison of fluorine-18 deoxyglucose and O-15 water PET in temporal lobe epilepsy
8. Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: Comparison with MR imaging and positron emission tomography
9. Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging
10. Ipsilaterar and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures
11. Is amygdalohippocampectomy really selective in medial temporal lobe epilepsy? A study using positron emission tomography with (18) fluorodeoxyglucose
12. Postoperative changes in cerebral metabolism in temporal lobe epilepsy
13. Planned ictal FDG PET imaging for localization of extratemporal epileptic foci
14. [11 C]Flumazenil binding in the medial temporal robe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology
15. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI
16. Neocortical abnormalities of 11C-flumazenil PET in mesial temporal lobe epilepsy
17. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy
18. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy
19. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome
20. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia
21. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy
22. Presurgical lateralization of seizure focus and language dominant hemisphere with O-15 water PET imaging
23. Focal functional deficits in temporal lobe epilepsy on PET scans and the intracarotid amytal procedure: Comparison of patients with unitemporal epilepsy and those requiring intracranial recordings
24. Correlation of temporal lobe glucose metabolism with the Wada memory test
25. The effects of mesial temporal and cerebellar hypometabolism on learning and memory
26. Imaging cognitive function in epilepsy
27. Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression
28. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy
29. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage
30. Hippocampal volume and glucose metabolism in temporal lobe epileptic foci
31. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat
32. Ratio-images calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy
33. Persistent postictal hyperperfusion demonstrated with PET
34. Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy
35. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy
36. Postnatal maturation of human GABAA receptors measured with positron emission tomography
37. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors
38. GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy
39. Quantitation of benzodiazepine receptor binding with PET [110]iomazenil and SPECT [1231]iomazenil: Preliminary results of a direct comparison in healthy human subjects
40. Central benzodiazepine receptors in malformations of cortical development: A quantitative study
41. [110](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis
42. W PET imaging of 5HT1A receptors in temporal lobe epilepsy
43. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy
44. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures
45. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy
46. A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: Methodology and preliminary findings
47. Longitudinal quantitative hippocampal magnetic resonance imaging study of adults with newly diagnosed partial seizures: One-year follow-up results
48. Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy
49. Natural history of metabolic abnormalities in children with partial epilepsy determined by FDG-PET
50. Sturge-Weber syndrome: Correlation between clinical course and FDG-PET findings
51. Relationship of seizure frequency to hippocampus volume and metabolism in temporal lobe epilepsy
52. Recommendations for functional neuroimaging of persons with epilepsy